Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL.

15 Jul 2020

Researchers engineer new nanobodies from Ilama blood cells against COVID-19 infection

UK scientists declared recently that antibodies extracted from llamas have been demonstrated to neutralize the SARS-CoV-2 virus in laboratory tests.

14 Jul 2020

New study could help develop artificial photosynthetic technology for energy production

Biological membranes perform significant functions in shaping the cell, transporting molecules, sensing the external environment, and producing energy for life.

14 Jul 2020

UTMB researchers uncover new mechanism for designing dengue therapeutics

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a new mechanism for designing antiviral drugs for dengue virus. The study is currently available in Proceedings of the National Academy of Sciences.

14 Jul 2020

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston.

14 Jul 2020

New radiotracer provides a quantitative measure of disease progression after stroke

A new radiotracer, 18F-SynVesT-2, can directly assess synaptic density changes in the brain, providing an objective and quantitative measure of disease progression after stroke.

14 Jul 2020

UMass Amherst researchers synthesize artificial fuel for muscle

A chemist and kinesiologist got on a bus, but this isn't the set-up to a joke. Instead, kinesiologist and lead author Ned Debold and chemist Dhandapani Venkataraman, "DV," began talking on their bus commute to the University of Massachusetts Amherst and discovered their mutual interest in how energy is converted from one form to another - for Debold, in muscle tissue and for DV, in solar cells.

14 Jul 2020

Researchers test the efficiency of F2X Entry library to expedite the quest for active compounds

For drugs to be effective, they usually have to dock to proteins in the organism. Like a key in a lock, part of the drug molecule must fit into recesses or cavities of the target protein.

14 Jul 2020

Study shows cathepsin B can be used as biomarker for traumatic brain injury

Scientists at the Walter Reed Army Institute for Research (WRAIR) have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.

14 Jul 2020

Researchers explore the reproduction of adenoviruses in cells

An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

14 Jul 2020

Analysis of nearly 300 new SARS-CoV-2 antibodies reveals a common feature

An analysis of nearly 300 recently identified human SARS-CoV-2 antibodies uncovered a gene frequently used in antibodies that most effectively target the virus. The results contribute to growing structural insight that will be needed for successful vaccine development against SARS-CoV-2.

14 Jul 2020

Study solves longstanding mysteries about frogs

Frogs and toads are green for a very good reason - it makes them harder to see in their leafy environments. Good camouflage allows them to eat and not be eaten. But not all frogs have arrived at this life-saving greenness in the same way.

14 Jul 2020

Common molecular feature in SARS-CoV-2 neutralizing antibodies discovered

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

14 Jul 2020

Researchers use DSC-based method to measure protein-ligand binding

A team of researchers from Kazan Federal University, Russia, led by Dr. Igor Sedov, reported an application of capillary differential scanning calorimetry technique for the study of the binding of albumin, a plasma transport protein, with different drug ligands.

14 Jul 2020

Scientists discover new antiviral drug against paramyxovirus

A new antiviral drug that is effective against a broad range of human pathogens in the paramyxovirus family, such as the human parainfluenzaviruses and measles virus, has been discovered by researchers in the Institute for Biomedical Sciences at Georgia State University.

14 Jul 2020

New technology generates immune response by delivering antigens to APCs in the spleen

Red blood cells do more than shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens on their surfaces, neutralizing them, and presenting them to immune cells in the spleen and liver.

14 Jul 2020

Study calls for alternative options to clean disposable surgical masks

A University of Cincinnati researcher is advising against using two widely available sterilization methods to clean disposable surgical masks and N95 respirators for reuse in the midst of the coronavirus pandemic.

14 Jul 2020

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

14 Jul 2020

New mutation in common flu subtype helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

13 Jul 2020

Researchers discover promising drug candidate for treatment of brain disorders

Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) discovered a novel chemical compound, which has the potential to became a new drug for the treatment of core symptoms of brain disorders like Down syndrome and autism.

13 Jul 2020

Protein News and Research

Further Reading

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Researchers engineer new nanobodies from Ilama blood cells against COVID-19 infection

New study could help develop artificial photosynthetic technology for energy production

UTMB researchers uncover new mechanism for designing dengue therapeutics

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

New radiotracer provides a quantitative measure of disease progression after stroke

UMass Amherst researchers synthesize artificial fuel for muscle

Researchers test the efficiency of F2X Entry library to expedite the quest for active compounds

Study shows cathepsin B can be used as biomarker for traumatic brain injury

Researchers explore the reproduction of adenoviruses in cells

Analysis of nearly 300 new SARS-CoV-2 antibodies reveals a common feature

Study solves longstanding mysteries about frogs

Common molecular feature in SARS-CoV-2 neutralizing antibodies discovered

Researchers use DSC-based method to measure protein-ligand binding

Scientists discover new antiviral drug against paramyxovirus

New technology generates immune response by delivering antigens to APCs in the spleen

Study calls for alternative options to clean disposable surgical masks

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

New mutation in common flu subtype helps evade immune response

Researchers discover promising drug candidate for treatment of brain disorders

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics